Both Novo Nord's Dual GIP/GLP-1 and copyright are modern medications created for treating diabetes and promoting weight reduction . However, they operate through distinct pathways. copyright is a GLP-1 receptor site activator , while Zepotide acts as a dual GIP and GLP-1 activator , potentially offering a greater impact on both blood sugar manageme